 SANTA MONICA, Calif., Sept. 22, 2021 GLOBE NEWSWIRE -- BioVie Inc., NASDAQ: BIVI BioVie or the Company a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders and advanced liver disease, today announced the participation of its management team at the Cantor Virtual Global Healthcare Conference to be held September 27-30, 2021. 